Ionis Pharmaceuticals, Inc.
IONS
$55.37
-$0.65-1.16%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -110.72% | 28.61% | 15.97% | 28.56% | 26.67% |
| Total Depreciation and Amortization | 24.60% | 13.84% | 3.20% | -7.68% | -3.66% |
| Total Amortization of Deferred Charges | 17.02% | 14.25% | 3.26% | -0.99% | -0.93% |
| Total Other Non-Cash Items | -9.66% | -6.57% | 0.57% | 5.03% | 23.19% |
| Change in Net Operating Assets | 27.98% | -260.98% | 75.54% | -1.06% | -7.11% |
| Cash from Operations | -115.31% | -81.48% | 46.38% | 29.81% | 33.36% |
| Capital Expenditure | -8.36% | -13.62% | -13.61% | -193.45% | -393.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 282.21% | 989.88% | -155.03% | 226.48% | -184.50% |
| Cash from Investing | 204.48% | 323.29% | -107.25% | 191.70% | -223.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,467.61% | -499.49% | -499.53% | -27,136.59% | 34.25% |
| Issuance of Common Stock | -46.68% | -50.60% | -63.15% | -84.87% | 607.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -30.31% | 60.04% | 41.37% | -92.80% | 1,216.73% |
| Foreign Exchange rate Adjustments | -145.30% | 354.79% | 357.14% | -52.30% | 1,585.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,493.51% | -7.22% | 182.82% | 121.40% | 102.53% |